Skip to Main Content

Author Details

Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
1996
189
46
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36148636Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients.J Pathol Clin Res2023
35579862Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events.Cancer Rep (Hoboken)2023
36148636Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients.J Pathol Clin Res2023
37664618EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping.iScience2023
37835531Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes.Cancers (Basel)2023
36973999Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma.Pediatr Blood Cancer2023
37213300Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab.Front Oncol2023
37149691Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence.Nat Commun2023
37174002Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report.Cancers (Basel)2023
36603685Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.Biochem Pharmacol2023
37509390Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2.Cancers (Basel)2023
37507917Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs.Antioxidants (Basel)2023
37664618EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping.iScience2023
37509390Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2.Cancers (Basel)2023
37507917Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs.Antioxidants (Basel)2023
37835531Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes.Cancers (Basel)2023
35579862Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events.Cancer Rep (Hoboken)2023
37149691Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence.Nat Commun2023
37213300Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab.Front Oncol2023
37174002Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report.Cancers (Basel)2023
36973999Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma.Pediatr Blood Cancer2023
36603685Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.Biochem Pharmacol2023
34974029SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas.J Control Release2022
35715791MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.BMC Cancer2022
35457141AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia.Int J Mol Sci2022
35393436MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.Cell Death Discov2022
36305736BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.Cancer Discov2022
36358891Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies.Cancers (Basel)2022
35695059The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.EMBO Mol Med2022
35681553Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review.Cancers (Basel)2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35354905Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.Oncogene2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36714878Human EWS-FLI protein recapitulates in Drosophila the neomorphic functions that induce Ewing sarcoma tumorigenesis.PNAS Nexus2022
35254670Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients.J Pathol2022
34974029SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas.J Control Release2022
35695059The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.EMBO Mol Med2022
35393436MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.Cell Death Discov2022
35457141AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia.Int J Mol Sci2022
35715791MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.BMC Cancer2022
35681553Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review.Cancers (Basel)2022
35354905Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.Oncogene2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36714878Human EWS-FLI protein recapitulates in Drosophila the neomorphic functions that induce Ewing sarcoma tumorigenesis.PNAS Nexus2022
36305736BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.Cancer Discov2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36358891Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies.Cancers (Basel)2022
35254670Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients.J Pathol2022
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
31876779WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1.J Pediatr Hematol Oncol2021
  • 1 - 50 of 378

Recommended Authors

Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 57
Juan C Vasquez
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Matthew D Wood
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 20
Amy Smith
Arnold Palmer Hospital for Children
Career Start Year 2003
Number of shared co-authors 47
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 20
Nicholas G Gottardo
Perth Children's Hospital
Career Start Year 2002
Number of shared co-authors 60
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 29
Noah Federman
University of California los angeles
Career Start Year 2001
Number of shared co-authors 8
Piergiorgio Modena
S. Anna General Hospital
Career Start Year 2000
Number of shared co-authors 37
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 78
Scott C Borinstein
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 6
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Career Start Year 1998
Number of shared co-authors 54
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 31
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 35
Anne Bendel
Children's Hospitals and Clinics of Minnesota
Career Start Year 1993
Number of shared co-authors 87
Richard J Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 96
Murali Chintagumpala
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 1990
Number of shared co-authors 64
Inge M Ambros
St. Anna Children's Cancer Research Institute
Career Start Year 1990
Number of shared co-authors 14
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 56
Alberto S Pappo
St Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 26
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 10
Shifra Ash
Ruth Rappaport Children's Hospital
Career Start Year 1988
Number of shared co-authors 3
Ruth Ladenstein
Children's Cancer Research Institute
Career Start Year 1986
Number of shared co-authors 33
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 8
Jean Michon
Institut Curie
Career Start Year 1983
Number of shared co-authors 24
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 57
Peter F Ambros
Children's Cancer Research Institute, Medical University of Vienna
Career Start Year 1978
Number of shared co-authors 25
Charles Patrick Reynolds
Cancer Center, Texas Tech University Health Sciences Center
Career Start Year 1975
Number of shared co-authors 10
Michelle Haber
School of Clinical Medicine
Career Start Year 1973
Number of shared co-authors 20
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 40

Collaborators

Carmen de Torres
Co-authored papers 53
Angel M Carcaboso
Co-authored papers 41
Ofelia Cruz
Co-authored papers 35
Mariona Suñol
Co-authored papers 33
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 23
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 19
Oscar M Tirado
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Co-authored papers 18
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 15
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 15
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 14
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 13
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers 12
Betty Luu
University of Wollongong
Co-authored papers 12
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 12
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 11
Roger E McLendon
Co-authored papers 11
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 10
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers 10
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers 10
Wies??awa Grajkowska
Children's Memorial Health Institute
Co-authored papers 10
Eric Bouffet
The Hospital for Sick Children
Co-authored papers 10
Andreas von Deimling
Co-authored papers 10
Pim J French
Erasmus MC Cancer Institute
Co-authored papers 10
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 10
Toshihiro Kumabe
Kitasato University School of Medicine
Co-authored papers 9
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 9
Seung-Ki Kim
Seoul National University Children's Hospital
Co-authored papers 9
William A Weiss
University of California san francisco
Co-authored papers 9
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers 9
Uri Tabori
Co-authored papers 9
Release 1.2